DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
LIFIRAFENIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase B-raf inhibitor
LIFIRAFENIB
×
Maximum Phase:
1
First Approval:
None
UNII:
8762XZS5ZF
Molecule Type:
Small molecule
Molecular Formula:
C25H17F3N4O3
Molecular Weight:
478.43
AlogP:
5.3
PSA:
89.13
HBD:
2.0
HBA:
#RotB:
3.0
Source:
HYODEOXYCHOLIC_ACID
1
Small molecule
Investigational
Unknown
Unknown
Hypercholesterolemia
LXR-alpha agonist
HYODEOXYCHOLIC_ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
7A33Y6EHYK
Molecule Type:
Small molecule
Molecular Formula:
C24H40O4
Molecular Weight:
392.58
AlogP:
4.48
PSA:
77.76
HBD:
3.0
HBA:
#RotB:
4.0
Source:
KANAMYCIN A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
KANAMYCIN A
×
Maximum Phase:
1
First Approval:
None
UNII:
EQK9Q303C5
Molecule Type:
Small molecule
Molecular Formula:
C18H36N4O11
Molecular Weight:
484.5
AlogP:
-7.29
PSA:
282.61
HBD:
11.0
HBA:
#RotB:
6.0
Source:
URAPIDIL HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Aortic Dissection
Unknown
URAPIDIL HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
PVU92PZO12
Molecule Type:
Small molecule
Molecular Formula:
C20H30ClN5O3
Molecular Weight:
423.95
AlogP:
0.72
PSA:
71.74
HBD:
1.0
HBA:
#RotB:
7.0
Source:
MLN-8054
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Colonic Neoplasms; Neoplasms; Pancreatic Neoplasms
Serine/threonine-protein kinase Aurora-A inhibitor
MLN-8054
×
Maximum Phase:
1
First Approval:
None
UNII:
BX854EHD63
Molecule Type:
Small molecule
Molecular Formula:
C25H15ClF2N4O2
Molecular Weight:
476.87
AlogP:
5.87
PSA:
87.47
HBD:
2.0
HBA:
#RotB:
4.0
Source:
KW-2478
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Myeloma
Unknown
KW-2478
×
Maximum Phase:
1
First Approval:
None
UNII:
E628ZH6U2C
Molecule Type:
Small molecule
Molecular Formula:
C30H42N2O9
Molecular Weight:
574.67
AlogP:
2.27
PSA:
127.23
HBD:
2.0
HBA:
#RotB:
16.0
Source:
PYRUVATE SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Asthma; Cystic Fibrosis; Severe Acute Respiratory Syndrome
Unknown
PYRUVATE SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
POD38AIF08
Molecule Type:
Small molecule
Molecular Formula:
C3H3NaO3
Molecular Weight:
110.04
AlogP:
-0.34
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
1.0
Source:
NERINDOCIANINE
1
Small molecule
Investigational
Unknown
Unknown
Molecular Imaging; Wounds and Injuries
Unknown
NERINDOCIANINE
×
Maximum Phase:
1
First Approval:
None
UNII:
1GZ5G85KVT
Molecule Type:
Small molecule
Molecular Formula:
C44H52N2O16S5
Molecular Weight:
1025.23
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RALIMETINIB
1
Small molecule
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Glioblastoma; Neoplasms; Ovarian Neoplasms; Breast Neoplasms
MAP kinase p38 alpha inhibitor
RALIMETINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
73I34XW4HD
Molecule Type:
Small molecule
Molecular Formula:
C24H29FN6
Molecular Weight:
420.54
AlogP:
5.55
PSA:
85.41
HBD:
2.0
HBA:
#RotB:
3.0
Source:
INDIBULIN
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms
Tubulin inhibitor
INDIBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
80K4H2RB8P
Molecule Type:
Small molecule
Molecular Formula:
C22H16ClN3O2
Molecular Weight:
389.84
AlogP:
4.56
PSA:
63.99
HBD:
1.0
HBA:
#RotB:
5.0
Source:
VINPOCETINE
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy; Diabetic Nephropathies; Attention Deficit Disorder with Hyperactivity
Unknown
VINPOCETINE
×
Maximum Phase:
1
First Approval:
None
UNII:
543512OBTC
Molecule Type:
Small molecule
Molecular Formula:
C22H26N2O2
Molecular Weight:
350.46
AlogP:
4.15
PSA:
34.47
HBD:
0.0
HBA:
#RotB:
3.0
Source:
5-METHYL-2'-FLUOROARAURACIL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
5-METHYL-2'-FLUOROARAURACIL
×
Maximum Phase:
1
First Approval:
None
UNII:
37F7D05ANB
Molecule Type:
Small molecule
Molecular Formula:
C10H13FN2O5
Molecular Weight:
260.22
AlogP:
-1.57
PSA:
104.55
HBD:
3.0
HBA:
#RotB:
2.0
Source:
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)
1
Small molecule
Investigational
Unknown
Unknown
Acquired Immunodeficiency Syndrome
Unknown
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)
×
Maximum Phase:
1
First Approval:
None
UNII:
HHT01ZNK31
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-5153
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin
Unknown
AZD-5153
×
Maximum Phase:
1
First Approval:
None
UNII:
C7C7U6YEAO
Molecule Type:
Small molecule
Molecular Formula:
C25H33N7O3
Molecular Weight:
479.59
AlogP:
2.06
PSA:
88.33
HBD:
0.0
HBA:
#RotB:
7.0
Source:
R-306465
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
R-306465
×
Maximum Phase:
1
First Approval:
None
UNII:
5WD7KK1IIQ
Molecule Type:
Small molecule
Molecular Formula:
C19H19N5O4S
Molecular Weight:
413.46
AlogP:
1.26
PSA:
115.73
HBD:
2.0
HBA:
#RotB:
4.0
Source:
KL-1333
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
KL-1333
×
Maximum Phase:
1
First Approval:
None
UNII:
NA2ZOL5UGM
Molecule Type:
Small molecule
Molecular Formula:
C14H12N2O2
Molecular Weight:
240.26
AlogP:
2.58
PSA:
62.82
HBD:
1.0
HBA:
#RotB:
1.0
Source:
ELINOGREL
1
Small molecule
Investigational
Unknown
Unknown
Kidney Diseases; Myocardial Infarction
Purinergic receptor P2Y12 antagonist
ELINOGREL
×
Maximum Phase:
1
First Approval:
None
UNII:
915Y8E749J
Molecule Type:
Small molecule
Molecular Formula:
C20H15ClFN5O5S2
Molecular Weight:
523.96
AlogP:
3.09
PSA:
142.16
HBD:
4.0
HBA:
#RotB:
5.0
Source:
IMD-2560
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor
IMD-2560
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-04776548
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
PF-04776548
×
Maximum Phase:
1
First Approval:
None
UNII:
CBR15S3HNJ
Molecule Type:
Small molecule
Molecular Formula:
C18H16FN3O3
Molecular Weight:
341.34
AlogP:
2.62
PSA:
67.59
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ILX23-7553
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vitamin D receptor agonist
ILX23-7553
×
Maximum Phase:
1
First Approval:
None
UNII:
O13QTC8612
Molecule Type:
Small molecule
Molecular Formula:
C27H38O3
Molecular Weight:
410.6
AlogP:
4.85
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
3.0
Source:
GSK159802
1
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
GSK159802
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-986158
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-986158
×
Maximum Phase:
1
First Approval:
None
UNII:
X8BW0MQ5PI
Molecule Type:
Small molecule
Molecular Formula:
C30H33N5O2
Molecular Weight:
495.63
AlogP:
5.54
PSA:
77.99
HBD:
1.0
HBA:
#RotB:
5.0
Source:
C-188-9
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Pancreatic Neoplasms; Idiopathic Pulmonary Fibrosis
Unknown
C-188-9
×
Maximum Phase:
1
First Approval:
None
UNII:
KZ3DLD11RQ
Molecule Type:
Small molecule
Molecular Formula:
C27H21NO5S
Molecular Weight:
471.53
AlogP:
5.88
PSA:
95.86
HBD:
3.0
HBA:
#RotB:
5.0
Source:
AZD-7687
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Diacylglycerol O-acyltransferase 1 inhibitor
AZD-7687
×
Maximum Phase:
1
First Approval:
None
UNII:
6QTJ9P2NYT
Molecule Type:
Small molecule
Molecular Formula:
C21H25N3O3
Molecular Weight:
367.45
AlogP:
3.61
PSA:
106.17
HBD:
2.0
HBA:
#RotB:
5.0
Source:
TENIFATECAN
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Pancreatic Neoplasms
Unknown
TENIFATECAN
×
Maximum Phase:
1
First Approval:
None
UNII:
7G0Y719Q80
Molecule Type:
Small molecule
Molecular Formula:
C55H72N2O9
Molecular Weight:
905.19
AlogP:
11.38
PSA:
143.25
HBD:
1.0
HBA:
#RotB:
19.0
Source:
RG7893
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG7893
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-7246
1
Small molecule
Investigational
Unknown
Unknown
Unknown
G protein-coupled receptor 44 antagonist
MK-7246
×
Maximum Phase:
1
First Approval:
None
UNII:
X0LHZ71TLK
Molecule Type:
Small molecule
Molecular Formula:
C21H21FN2O4S
Molecular Weight:
416.47
AlogP:
3.04
PSA:
79.61
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CARBENDAZIM
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
CARBENDAZIM
×
Maximum Phase:
1
First Approval:
None
UNII:
H75J14AA89
Molecule Type:
Small molecule
Molecular Formula:
C9H9N3O2
Molecular Weight:
191.19
AlogP:
1.74
PSA:
67.01
HBD:
2.0
HBA:
#RotB:
1.0
Source:
PLUMBAGIN
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
PLUMBAGIN
×
Maximum Phase:
1
First Approval:
None
UNII:
YAS4TBQ4OQ
Molecule Type:
Small molecule
Molecular Formula:
C11H8O3
Molecular Weight:
188.18
AlogP:
1.72
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
0.0
Source:
VLX-1005
1
Small molecule
Investigational
Unknown
Unknown
Thrombocytopenia
Unknown
VLX-1005
×
Maximum Phase:
1
First Approval:
None
UNII:
JKU4XCC48Y
Molecule Type:
Small molecule
Molecular Formula:
C21H19N3O4S2
Molecular Weight:
441.53
AlogP:
4.42
PSA:
100.55
HBD:
3.0
HBA:
#RotB:
7.0
Source:
RAVOXERTINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
MAP kinase ERK1 inhibitor
RAVOXERTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
R6AXV96CRH
Molecule Type:
Small molecule
Molecular Formula:
C21H18ClFN6O2
Molecular Weight:
440.87
AlogP:
3.16
PSA:
97.86
HBD:
2.0
HBA:
#RotB:
6.0
Source:
CINOBUFOTALIN
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CINOBUFOTALIN
×
Maximum Phase:
1
First Approval:
None
UNII:
L0QBZ37386
Molecule Type:
Small molecule
Molecular Formula:
C26H34O7
Molecular Weight:
458.55
AlogP:
2.91
PSA:
109.5
HBD:
2.0
HBA:
#RotB:
2.0
Source:
BMS-852927
1
Small molecule
Investigational
Unknown
Unknown
Hypercholesterolemia
LXR-alpha modulator
BMS-852927
×
Maximum Phase:
1
First Approval:
None
UNII:
H9649L8MZN
Molecule Type:
Small molecule
Molecular Formula:
C29H28Cl2F2N2O4S
Molecular Weight:
609.52
AlogP:
6.57
PSA:
92.42
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PL-225B
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Insulin-like growth factor I receptor inhibitor
PL-225B
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RODATRISTAT ETHYL
1
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary
Tryptophan 5-hydroxylase 1 inhibitor
RODATRISTAT ETHYL
×
Maximum Phase:
1
First Approval:
None
UNII:
507FY6OL37
Molecule Type:
Small molecule
Molecular Formula:
C29H31ClF3N5O3
Molecular Weight:
590.05
AlogP:
5.57
PSA:
102.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
1
2
…
82
83
84
85
86
87
88
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA